- Home
- WETH vs KAPA Comparison
WETH vs KAPA Comparison
Compare WETH & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- KAPA
- Stock Information
- Founded
- WETH 1992
- KAPA 2013
- Country
- WETH China
- KAPA United States
- Employees
- WETH N/A
- KAPA N/A
- Industry
- WETH
- KAPA
- Sector
- WETH
- KAPA
- Exchange
- WETH Nasdaq
- KAPA NYSE
- Market Cap
- WETH 10.9M
- KAPA 9.1M
- IPO Year
- WETH N/A
- KAPA 2024
- Fundamental
- Price
- WETH $0.90
- KAPA $0.65
- Analyst Decision
- WETH
- KAPA Strong Buy
- Analyst Count
- WETH 0
- KAPA 3
- Target Price
- WETH N/A
- KAPA $8.33
- AVG Volume (30 Days)
- WETH 40.4K
- KAPA 2.1M
- Earning Date
- WETH 08-18-2025
- KAPA 05-14-2025
- Dividend Yield
- WETH N/A
- KAPA N/A
- EPS Growth
- WETH N/A
- KAPA N/A
- EPS
- WETH 0.34
- KAPA N/A
- Revenue
- WETH $41,024,264.00
- KAPA N/A
- Revenue This Year
- WETH N/A
- KAPA N/A
- Revenue Next Year
- WETH N/A
- KAPA N/A
- P/E Ratio
- WETH $2.62
- KAPA N/A
- Revenue Growth
- WETH 2.86
- KAPA N/A
- 52 Week Low
- WETH $0.76
- KAPA $0.40
- 52 Week High
- WETH $3.62
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- WETH 38.18
- KAPA N/A
- Support Level
- WETH $0.86
- KAPA N/A
- Resistance Level
- WETH $0.98
- KAPA N/A
- Average True Range (ATR)
- WETH 0.06
- KAPA 0.00
- MACD
- WETH -0.00
- KAPA 0.00
- Stochastic Oscillator
- WETH 53.29
- KAPA 0.00
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.